We are Hexanedioic acid,2,2,3,3,4,4,5,5-octafluoro- CAS:336-08-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Synonyms：
Octafluoroadipic Acid
HEXANEDIOICACID,OCTAFLUORO
Octafluor-adipinsaeure
OCTAFLUOROHEXANEDIOIC ACID
octafluoro-hexanedioicaci
perfluoro-1,6-hexanedioic acid
PERFLUOROADIPIC ACID
PERFLUOROHEXANEDIOIC ACID
RARECHEM AL BO 0766
Octafluorohexanedioic Acid
Perfluoroadipic Acid
Perfluorohexanedioic Acid
Molecular Formula: C6H2F8O4
Molecular weight：290.06500
Appearance and properties: white crystals with a pungent smell
Density: 1.806g/cm3
Boiling point: 274.4ºC at 760 mmHg
Melting point: 132-134°C
Flash point: none
Refractive index: 1.345
Stability: Stable. Non-flammable. Incompatible with strong bases.
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.
Market News: But since the emergence of the Delta variant, the health ministry has twice reported a drop in the vaccine’s efficacy against infection and a slight decrease in its protection against severe disease.D:C-friedours-7-ene manufacturer.Another area AZ sees as a growth opportunity in China is rare diseases. In announcing its recent $39 billion acquisition of Alexion late last year, Soriot highlighted the potential to expand the Boston firm’s rare disease portfolio to China. N,N’-dibutyryl-oxalamide supplier In the US, however, ODAC in April voted to keep alive the accelerated approval for Tecentriq plus Abraxane (nab-paclitaxel) in mTNBC while additional confirmatory trials are ongoing. 7-chloro-5H-thieno[3,2-c]pyridin-4-one producer
